Denosumab - PDFSEARCH.IO - Document Search Engine

Denosumab
Results: 175

#	Item
121	Case Study Case Study 1 Patient: KL is a 52 year old female Medical Conditions: DVT 1 year ago, menopause x 6 months, Add to Reading List Source URL: www.qu.edu.qa Language: English - Date: 2014-03-26 06:41:48 Organic chemistry Medicine Osteopathies Cyclopropanes Moxifloxacin Alendronic acid Osteoporosis Denosumab Paracetamol Chemistry Analgesics Antipyretics
122	C:aDocumentsA20560-038exec.sum..doc Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-09-14 08:22:25 Health Medicine Pharmacology Clinical trial Denosumab Osteoporosis Bisphosphonates Alendronic acid Merck
123 $Amgen / Denosumab / Bisphosphonates / Drugs / Osteoporosis / Osteonecrosis of the jaw / Aromatase inhibitor / Hypovitaminosis D / Hip fracture / Medicine / Health / Pharmacology$	PRODUCT MONOGRAPH Prolia Pr (denosumab) Add to Reading List Source URL: www.amgen.ca Language: English - Date: 2014-07-03 07:23:15 Amgen Denosumab Bisphosphonates Drugs Osteoporosis Osteonecrosis of the jaw Aromatase inhibitor Hypovitaminosis D Hip fracture Medicine Health Pharmacology
124	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XGEVA® safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab) injection, for subcuta Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-06-13 10:38:35 Denosumab Zoledronic acid Giant-cell tumor of bone Osteonecrosis of the jaw Osteoprotegerin Multiple myeloma Chemotherapy Alendronic acid Medicine Bisphosphonates Amgen
125	Amgen-Sponsored Studies Amgen Countermeasures for Bone and Muscle Loss in Space and on Earth   Add to Reading List Source URL: www.astronautical.org Language: English - Date: 2013-07-28 17:10:21 Sclerostin Myostatin Osteoprotegerin Stamulumab Denosumab Osteoporosis Cachexia Activin type 2 receptors Teriparatide Biology Osteopathies Amgen
126	Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended ALENDRONATE SODIUM Add to Reading List Source URL: www.hma.eu Language: English - Date: 2011-07-06 13:23:05 Medicine Chemistry Osteopathies Health Osteoporosis Etidronic acid Aspirin Denosumab Bisphosphonates Alendronic acid Merck
127	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Monoclonal antibodies Crizotinib Pfizer Piperidines Pyrazoles Pyridines Denosumab Anaplastic lymphoma kinase Pralatrexate Medicine Oncology Chemistry
128	Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, Vermont[removed]Agency of Human Services Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-06-26 16:18:43 Osteoporosis Ibandronic acid Alendronic acid Denosumab Teriparatide Zoledronic acid Bisphosphonates Medicine Health
129	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Denosumab Crizotinib Metastatic breast cancer Eribulin Anaplastic lymphoma kinase Pralatrexate Oncology Radiation therapy Medicine Brain tumor Neuroblastoma
130	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Monoclonal antibodies Pyridines Eisai Eribulin Pralatrexate Denosumab Pfizer Amgen Food and Drug Administration Pharmacology Chemistry Pharmaceutical sciences

UPDATE